Home / Research and experimental development on biotechnology (except medical and veterinary science)

EXEGENESIS BIO SINGAPORE PTE. LTD.

Live CompanyUEN 202143510ZLocal Company

EXEGENESIS BIO SINGAPORE PTE. LTD. is a local company in Singapore with UEN 202143510Z. It was registered on 16 Dec 2021, 4 years ago. Its status is Live Company. Its main activity is research and experimental development on biotechnology (except medical and veterinary science).

UEN202143510Z
StatusLive Company
Entity typeLocal Company, Private Company Limited by Shares
Registered16 Dec 2021
Main activity (SSIC)72101 Research and experimental development on biotechnology (except medical and veterinary science)
Secondary activity86901 Medical laboratories
Address6 RAFFLES QUAY, #14-06, Singapore 048580
1246 companies at this address
AreaDowntown Core · District 1 (Raffles Place, Cecil, Marina, People's Park)
Nearest stationRaffles Place MRT, about 64 m
Officers7
Last annual return22 Jun 2026

Newer companies in research and experimental development on biotechnology (except medical and veterinary science)

  • DAYOU BIOTECHNOLOGY PTE. LTD.202637714W · 18 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PROBIO TECHNOLOGY PRIVATE LIMITED202636974G · 13 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • NEUTHERA PTE. LTD.202636842M · 12 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • PC BIOME INNOVATIONS PTE. LTD.202636514M · 11 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • THERALIFE53529115M · 1 Aug 2026 · Research and experimental development on biotechnology (except medical and veterinary science)
  • BIO-SUPPLY INNOVATIONS PTE. LTD.202633668E · 24 Jul 2026 · Research and experimental development on biotechnology (except medical and veterinary science)

Source: ACRA open data, data date 16 Sep 2026. Directors, shareholders and financial statements are not in the open data.